Email this article The role of sorafenib (Nexavar) in the treatment of inoperable locally advanced and disseminated renal cell cancer
- Authors: Matveyev B.P.1, Matveyev V.B.1, Volkova M.I.1
-
Affiliations:
- State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
- Issue: Vol 4, No 4 (2008)
- Pages: 11-16
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER
- Published: 30.12.2008
- URL: https://oncourology.abvpress.ru/oncur/article/view/1022
- DOI: https://doi.org/10.17650/1726-9776-2008-4-4-11-16
- ID: 1022
Cite item
Full Text
Abstract
Efficacy and safety issues of sorafenib (Nexavar) use in the treatment of patients with inoperable locally advanced and disseminated renal cell cancer are addressed. Several clinical studies of efficacy of treatment with sorafenib both in mono-regimen and combined with other drugs are discussed.
About the authors
B. P. Matveyev
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
Author for correspondence.
Moscow Russian Federation
V. B. Matveyev
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical SciencesMoscow Russian Federation
M. I. Volkova
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical SciencesMoscow Russian Federation
References
Supplementary files
